Abstract:Abstract Background/Objective: Tanshinone IIA, which is mainly used for the treatment of cardiovascular diseases, has been shown to inhibit the progression of a variety of cancers in recent years. In this study, we showed that tanshinone IIA could inhibit the proliferation of triple-negative breast cancer cells and promote their apoptosis. However, the specific mechanisms were not clear. Our research aims to clarify its mechanism. Method: At the first, the effects of tanshinone IIA on cell viability of triple-negative breast cancer cell lines were analyzed. Then a mouse transplanted tumor model was used to study the anti-cancer effect in vivo. The related targets and mechanisms of tanshinone IIA were predicted through network-based systems biology and molecular docking analysis. At last, molecular docking and the molecular biological techniques were used to evaluate the predicted target. Results: Tanshinone IIA could inhibit the cell proliferation after incubation for 24 h. At a concentration of 50 µM, Tanshinone IIA could half-inhibit the proliferation of 4T1 cells. Consistent with the results of the cell viability assays, Tan IIA induced the cancer cell apoptosis and resulted in a significant reduction in tumor volume. Then we analyzed the possible mechanisms with network-based systems biology, and predicted TP53, NF-κB, AKT, MYC and BCL-2 were the hub targets of Tan IIA for triple-negative breast cancer. P53 signaling pathway, PI3K/Akt pathway, the MAPK signaling pathway and the mTOR signaling pathways were the possible involved mechanisms. Using molecular docking analysis, we found Tan IIA has a high affinity for p53, Bcl-2 and NF-κB1, the binding energy were − 6.92, -6.07 and − 6.28 kcal/mol, respectively. Through western blotting assays, we further found the p53 protein expression was increased while Bcl-2 protein was decreased after Tan IIA treatment. These results verified that Tan IIA promotes apoptosis by down-regulating BCL2 and up-regulating TP53 in triple-negative breast cancer.Conclusion: Our findings revealed the mechanism of Tan IIA in promoting apoptosis and inhibiting proliferation in triple-negative breast cancer cells, which provides a theoretical and experimental basis for further research into the anticancer effects of Tan IIA.

Influence of Tanshinone IIA on apoptosis of human esophageal carcinoma Eca-109 cells and its molecular mechanism.

[The Variation of Caspase3 Activity in Tanshinone Induced NB4 Cells Apoptosis].

[A Study on the Effect of Tanshinone II A Against Human Breast Cancer in Vivo].

[A Study on Anticancer Activity of Tanshinone II A Against Human Breast Cancer].

Tanshinone IIA Promotes Apoptosis by Down-Regulating BCL2 and Up-Regulating TP53 in Triple-Negative Breast Cancer

Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer

Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells

Influence of Luteolin on the Apoptosis of Esophageal Cancer Eca109 Cells and Its Mechanism of Action

Tanshinone IIA Arrests Cell Cycle and Induces Apoptosis in 786-O Human Renal Cell Carcinoma Cells

Experimental study onα-Asarone-induced apoptosis in human esophageal carcinoma Eca-109 cell line I by regulating GADD153 and Smac mRNA expression levels

Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells.

Apoptosis inducing effect of Tanshinone ⅡA onhuman lung adenocarcinoma A549 cells

Tanshinone IIA Triggers P53 Responses and Apoptosis by RNA Polymerase II Upon DNA Minor Groove Binding.

Effect of Α-Asarone on Apoptosis of Eca-109 Cells and Expressions of XIAP and Caspase-3

Tanshinone II-A Induced Apoptosis of HepG2: Involvement of P53, Bcl-2 and Bax

Cistanche Tubulosa Phenylethanoid Glycosides Induce Apoptosis in Eca-109 Cells Via the Mitochondria-Dependent Pathway

Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells.

Investigation on Apoptosis Inducing Effect of Tanshinone ⅡA on Leukemia K562 Cells in Vitro

The effect of Tanshinone II a on proliferation and apoptosis of human gastric adenocarcinoma cell line SGC-7901

Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer

Apoptosis Inducing Effect of Tanshinone ⅡA on Human Nasopharyngeal Carcinoma CNE Cells